Janneke Wilschut

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 09, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen

|Jan 09, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

|Feb 09, 2023
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.

Zakile A Mfumbilwa, Janneke A Wilschut, Martijn J H G Simons

|Jul 26, 2020
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.

Ranjit Manchanda, Li Sun, Shreeya Patel

Pageof 1

Frequent Collaborators

3 joint publications

Zakile A Mfumbilwa

3 joint publications

Bram Ramaekers

3 joint publications

Manuela Joore

3 joint publications

Valesca Retèl